Mark-Andre Freyberg
Nessuna posizione attualmente
Profilo
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Precedenti posizioni note di Mark-Andre Freyberg
| Società | Posizione | Fine |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 30/09/2021 |
TemplaTech GmbH
 TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | President | 03/09/2007 |
| Dermatools Biotech GmbH | Founder | - |
| Cytopharma GmbH | Founder | - |
| Technische Universität Darmstadt | Corporate Officer/Principal | - |
Formazione di Mark-Andre Freyberg
| Technische Universität Darmstadt | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOXXMED AG | Health Technology |
| Aziende private | 3 |
|---|---|
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | Health Technology |
| Dermatools Biotech GmbH | |
| Cytopharma GmbH |
- Borsa valori
- Insiders
- Mark-Andre Freyberg
